🔬✨ Discover the surgical innovations reshaping bladder cancer care on a new Global Perspectives webinar on SIU Academy!
Join top global experts for this informative session on cutting-edge resection techniques, robotic & open radical cystectomy, and real-world strategies to improve outcomes in MIBC.
Watch open access on SIU Academy: https://t.co/aNiGktvYST
@fkorkes@jteoh_hk@UroMoschini@SimonemorraMD
Fantastic #bladdercancer session at #EMUC2025 with a brilliant discussion and a truly stellar panel. So much is chanhing with new treatments, and urologists need to be ready for what’s coming next.
@Uroweb
Explore the current definitions, treatment paradigms, & clinical dilemmas of NMIBC in this new #UROwebinar! The experts will address optimal risk stratification, tx duration, & future therapeutic directions.
Register here 👇
https://t.co/X5o7CVGuhW
@LAUrology_NL@UroMoschini
The Urothelial Cancer Update 2025 is officially underway. Esteemed experts are on stage sharing the latest advancements in diagnosis and treatment. What has been the most impactful session for you so far? Let us know in the comments! 👇
@cittasalute_to@unito@UroMolinette
@UroDocAsh Agree. In my opinion the disadvantage is regarding reconstruction: for neobladder is not possible to adeguately prepare the urethra and I prefer to not offer neobladder in these patients (I suppose functional outcomes are consistenly worse) for bricker increased risks of stenosis
A 🧵 on our recent study on surveillance for IR-NMIBC @EurUrolOncol https://t.co/trmFp9Yd0y
There is limited evidence on follow-up for IR-NMIBC.
We used data from >2000 primary Ta–T1 NMIBC to stratify IR-NMIBC by recurrence risk and propose a risk-adapted follow-up approach.
Complete vs partial TURBT for muscle-invasive #BladderCancer treatment. @UroLiedberg, @UroMoschini & @BenjaminPradere join @UroDocAsh in a discussion on the extent of transurethral resection of bladder tumor needed in #MIBC. They debate the value of complete resection when considering bladder-sparing approaches, neoadjuvant therapy, and clinical trials. #WatchNow on UroToday > https://t.co/uTCAuHIFES